Intrinsic Edge Capital Management’s Globus Medical GMED Stock Holding History

Intrinsic Edge Capital Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-51,651	Closed	-$3.96M	–	229
2021 Q3	$3.96M	Buy	51,651 +11,919	+30%	+$957K	0.27%	130
2021 Q2	$3.08M	Buy	39,732 +9,732	+32%	+$692K	0.18%	173
2021 Q1	$1.85M	Buy	+30,000	New	+$1.9M	0.13%	199
2020 Q2	–	Sell	-80,000	Closed	-$3.4M	–	227
2020 Q1	$3.4M	Buy	+80,000	New	+$3.95M	0.45%	69

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Intrinsic Edge Capital Management's GMED Position: Q4 2021 in Review

Intrinsic Edge Capital Management sold out of Globus Medical (GMED) in Q4 2021, closing a stake of 51,651 shares — an estimated $3.96M sold.

Intrinsic Edge Capital Management first reported a position in GMED in Q1 2020 and held it in 4 quarters. The position peaked at $3.96M in Q3 2021. 373 funds tracked by Wall St. Rank hold GMED as of Q4 2021.

Intrinsic Edge Capital Management reported no remaining Globus Medical position as of Q4 2021 after selling out during the quarter.
Intrinsic Edge Capital Management sold 51,651 Globus Medical shares in Q4 2021, an estimated $3.96M.
Intrinsic Edge Capital Management first reported a position in Globus Medical in Q1 2020 and held it in 4 quarters.
Intrinsic Edge Capital Management's Globus Medical position peaked at $3.96M in Q3 2021.
373 funds tracked by Wall St. Rank held Globus Medical as of Q4 2021.

Based on Intrinsic Edge Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.